These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
643 related items for PubMed ID: 25771080
1. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer. Meshkat B, Prichard RS, Al-Hilli Z, Bass GA, Quinn C, O'Doherty A, Rothwell J, Geraghty J, Evoy D, McDermott EW. Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080 [Abstract] [Full Text] [Related]
2. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening? Erbas B, Amos A, Fletcher A, Kavanagh AM, Gertig DM. Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971 [Abstract] [Full Text] [Related]
3. The frequency of presentation and clinico-pathological characteristics of symptomatic versus screen detected ductal carcinoma in situ of the breast. Barnes NL, Dimopoulos N, Williams KE, Howe M, Bundred NJ. Eur J Surg Oncol; 2014 Mar; 40(3):249-54. PubMed ID: 24433818 [Abstract] [Full Text] [Related]
4. Characteristics and behaviour of screen-detected ductal carcinoma in situ of the breast: comparison with symptomatic patients. Koh VC, Lim JC, Thike AA, Cheok PY, Thu MM, Tan VK, Tan BK, Ong KW, Ho GH, Tan WJ, Tan Y, Salahuddin AS, Busmanis I, Chong AP, Iqbal J, Thilagaratnam S, Wong JS, Tan PH. Breast Cancer Res Treat; 2015 Jul; 152(2):293-304. PubMed ID: 26077641 [Abstract] [Full Text] [Related]
5. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status. Miglioretti DL, Zhu W, Kerlikowske K, Sprague BL, Onega T, Buist DS, Henderson LM, Smith RA, Breast Cancer Surveillance Consortium. JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844 [Abstract] [Full Text] [Related]
6. Comparison between screen-detected and symptomatic breast cancers according to molecular subtypes. Kim J, Lee S, Bae S, Choi MY, Lee J, Jung SP, Kim S, Choe JH, Kim JH, Kim JS, Lee JE, Nam SJ, Yang JH. Breast Cancer Res Treat; 2012 Jan; 131(2):527-40. PubMed ID: 22042364 [Abstract] [Full Text] [Related]
7. Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program. Chiarelli AM, Prummel MV, Muradali D, Majpruz V, Horgan M, Carroll JC, Eisen A, Meschino WS, Shumak RS, Warner E, Rabeneck L. J Clin Oncol; 2014 Jul 20; 32(21):2224-30. PubMed ID: 24934793 [Abstract] [Full Text] [Related]
14. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study. Ciatto S, Houssami N, Bernardi D, Caumo F, Pellegrini M, Brunelli S, Tuttobene P, Bricolo P, Fantò C, Valentini M, Montemezzi S, Macaskill P. Lancet Oncol; 2013 Jun 20; 14(7):583-9. PubMed ID: 23623721 [Abstract] [Full Text] [Related]
16. Aggressiveness features and outcomes of true interval cancers: comparison between screen-detected and symptom-detected cancers. Domingo L, Blanch J, Servitja S, Corominas JM, Murta-Nascimento C, Rueda A, Redondo M, Castells X, Sala M. Eur J Cancer Prev; 2013 Jan 20; 22(1):21-8. PubMed ID: 22584215 [Abstract] [Full Text] [Related]
17. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project. Ng EH, Ng FC, Tan PH, Low SC, Chiang G, Tan KP, Seow A, Emmanuel S, Tan CH, Ho GH, Ng LT, Wilde CC. Cancer; 1998 Apr 15; 82(8):1521-8. PubMed ID: 9554530 [Abstract] [Full Text] [Related]
20. MRI of the breast as part of the assessment in population-based mammography screening. Bick U, Engelken F, Diederichs G, Dzyuballa R, Ortmann M, Fallenberg EM. Rofo; 2013 Sep 15; 185(9):849-56. PubMed ID: 23740312 [Abstract] [Full Text] [Related] Page: [Next] [New Search]